Cost-utility and cost-effectiveness analysis of disease-modifying drugs of relapsing–remitting multiple sclerosis: a systematic review
Article in Health Economics Review (February 2024)
The most recent citing publications are shown below. View all 55 publications that cite this research output on Dimensions.
Article in Health Economics Review (February 2024)
Article in Autoimmunity Reviews (November 2023)
Article in Value in Health (October 2023)